INS and diabetes mellitus: The phenotype of patients with diabetes due to a homozygous (or compound heterozygous) mutation in INS is characterized by severe intrauterine growth retardation (birth weight, <1 percentile) and neonatal diabetes, most likely reflecting severe insulin deficiency in the pre- and postnatal life, respectively.